| Literature DB >> 27646706 |
Pamela J Kaisaki1, Georg W Otto1, Karène Argoud1, Stephan C Collins1, Robert H Wallis1, Steven P Wilder1, Anthony C Y Yau1, Christophe Hue2, Sophie Calderari2, Marie-Thérèse Bihoreau1, Jean-Baptiste Cazier3, Richard Mott4, Dominique Gauguier5,2.
Abstract
To test the impact of genetic heterogeneity on cis- and trans-mediated mechanisms of gene expression regulation, we profiled the transcriptome of adipose tissue in 20 inbred congenic strains derived from diabetic Goto-Kakizaki (GK) rats and Brown-Norway (BN) controls, which contain well-defined blocks (1-183 Mb) of genetic polymorphisms, and in 123 genetically heterogeneous rats of an (GK × BN)F2 offspring. Within each congenic we identified 73-1351 differentially expressed genes (DEGs), only 7.7% of which mapped within the congenic blocks, and which may be regulated in cis The remainder localized outside the blocks, and therefore must be regulated in trans Most trans-regulated genes exhibited approximately twofold expression changes, consistent with monoallelic expression. Altered biological pathways were replicated between congenic strains sharing blocks of genetic polymorphisms, but polymorphisms at different loci also had redundant effects on transcription of common distant genes and pathways. We mapped 2735 expression quantitative trait loci (eQTL) in the F2 cross, including 26% predominantly cis-regulated genes, which validated DEGs in congenic strains. A hotspot of >300 eQTL in a 10 cM region of chromosome 1 was enriched in DEGs in a congenic strain. However, many DEGs among GK, BN and congenic strains did not replicate as eQTL in F2 hybrids, demonstrating distinct mechanisms of gene expression when alleles segregate in an outbred population or are fixed homozygous across the entire genome or in short genomic regions. Our analysis provides conceptual advances in our understanding of the complex architecture of genome expression and pathway regulation, and suggests a prominent impact of epistasis and monoallelic expression on gene transcription.Entities:
Keywords: Goto–Kakizaki; diabetes mellitus; eQTL; epistasis; quantitative trait locus
Year: 2016 PMID: 27646706 PMCID: PMC5100866 DOI: 10.1534/g3.116.033274
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
Figure 1Schematic representation of the exchanged genomic regions in congenic strains. Red bars show the GK genomic blocks introgressed onto the genomic background of the BN strain in BN.GK congenic series. Blue bars show the BN genomic blocks introgressed onto the genomic background of the GK strain in GK.BN congenic strains. Details of the genomic intervals targeted in each congenic strain are given in Table S1.
Overview of fat gene transcription profiling in congenic strains of the GK rat
| Replicated GK | Replicated eQTL | |||||||
|---|---|---|---|---|---|---|---|---|
| Congenic Name | Gene Density | Total DEGs | Transcriptional Footprint | DEGs in Congenic Intervals, % | % | Replicated | ||
| BN.GK1b | 203 (128) | 1257 | 6.20 | 12 (1.0) | 120 (3) | 9.5 (2.5) | 179 (14) | 6 |
| BN.GK1d | 24 (11) | 1239 | 51.71 | 1 (0.1) | 76 (0) | 6.1 (0) | 171 (14) | 0 |
| BN.GK1f | 394 (224) | 874 | 2.24 | 21 (2.3) | 77 (7) | 8.7 (9.1) | 148 (17) | 8 |
| BN.GK1h | 994 (620) | 1039 | 1.05 | 46 (4.4) | 92 (15) | 8.8 (16.3) | 176 (17) | 23 |
| BN.GK1p | 1407 (812) | 1351 | 0.96 | 58 (4.3) | 132 (20) | 9.7 (15.2) | 268 (20) | 155 |
| BN.GK1q | 90 (45) | 947 | 10.57 | 2 (0.2) | 54 (0) | 5.7 (0) | 148 (16) | 2 |
| BN.GK1t | 9 (4) | 471 | 52.56 | 0 (0) | 30 (0) | 6.3 (0) | 88 (19) | 0 |
| BN.GK1u | 541 (363) | 1337 | 2.48 | 19 (1.3) | 114 (9) | 8.5 (7.9) | 196 (15) | 11 |
| BN.GK1v | 210 (49) | 931 | 4.45 | 6 (0.6) | 55 (2) | 5.9 (3.6) | 122 (13) | 28 |
| BN.GK2c | 1243 (627) | 101 | 0.08 | 27 (26.7) | 33 (16) | 32.7 (48.5) | 36 (36) | 28 |
| BN.GK4b | 1578 (812) | 232 | 0.15 | 26 (11.1) | 45 (13) | 19.2 (28.9) | 49 (21) | 26 |
| BN.GK5a | 511 (275) | 94 | 0.18 | 9 (9.6) | 18 (6) | 19.1 (33.3) | 17 (18) | 10 |
| BN.GK5c | 259 (112) | 557 | 2.15 | 12 (2.2) | 44 (6) | 7.9 (13.6) | 67 (12) | 5 |
| BN.GK7a | 576 (345) | 91 | 0.16 | 13 (14.3) | 30 (8) | 33.0 (26.7) | 30 (33) | 14 |
| BN.GK7d | 275 (151) | 73 | 0.27 | 4 (5.5) | 9 (2) | 12.3 (22.2) | 13 (18) | 5 |
| BN.GK8b | 448 (259) | 312 | 0.71 | 8 (2.5) | 36 (5) | 11.3 (13.9) | 25 (8) | 7 |
| BN.GK10a | 1432 (870) | 294 | 0.21 | 38 (12.9) | 34 (12) | 11.6 (35.3) | 50 (17) | 25 |
| GK.BN7a | 1014 (580) | 54 | 0.05 | 11 (20.4) | 19 (6) | 35.2 (31.6) | 16 (30) | 12 |
| GK.BN8 | 1149 (675) | 486 | 0.42 | 32 (6.6) | 74 (12) | 15.2 (16.2) | 71 (15) | 19 |
| GK.BN10_7a | 2166 (1276) | 140 | 0.07 | 39 (27.7) | 49 (22) | 34.8 (44.9) | 54 (38) | 40 |
Gene density indicates the number of genes localized in the congenic interval and in parentheses those represented on the Illumina BeadChip. Transcriptome data were analyzed to identify differentially expressed genes (DEGs) (P < 0.05) in BN.GK and GK.BN congenic series when compared to BN and GK controls, respectively. The transcriptional regulatory footprint of each congenic region was calculated as the ratio of the total number of DEGs between congenics and control to the number of genes localized in the corresponding congenic interval. The number and percentage of DEGs localized in each congenic interval were determined. Replication of expression changes in parental strains and in congenics was evaluated by the number (N) and percentage of genes found consistently differentially expressed (same direction of expression change) between congenic and controls and between GK and BN, including those localized in congenic intervals (in parentheses). Replicated eQTL effects correspond to DEG between congenic and controls that are linked to eQTLs showing consistent direction of expression changes mediated by GK alleles in the F2 rats and in congenics. Cis eQTLs replicated in congenics are shown. Full details of individual DEG in inbred strains (GK, BN, and congenics) and eQTLs are given in Table S4
Figure 2Patterns of gene transcription regulation in white adipose tissue by GK/BN polymorphisms in GK and BN rats and in congenic strains. Conserved gene expression patterns between BN.GK congenic rats and controls and between GK and BN rats are shown for all differentially expressed genes (A) and those localized in congenic intervals (B). Conservation of gene expression changes in congenics targeting overlapping genomic regions is illustrated by plotting expression ratio in strains BN.GK1b and BN.GK1f (C) and in reciprocal strains BN.GK8b and GK.BN8a (D). Full details of differentially expressed genes are given in Table S4.
Figure 3Patterns of gene transcription regulation in congenic strains. Conserved allelic effects on genome-wide gene expression regulation in adipose tissue were tested in BN.GK7a and BN.GK10a congenics and in reciprocal strains GK.BN7a and GK.BN10_7a targeting largely overlapping genomic regions. Genomic positions of genes significantly differentially expressed (P < 0.05) between BN.GK congenic and BN controls and between GK.BN congenic and GK controls are plotted along the x-axes and gene expression ratios are shown along the y-axes. Chromosomal location of genes is color coded. Full details of differentially expressed genes, including genes that are localized in the congenic intervals and may be regulated in cis, are given in Table S4.
Figure 4Global effects of GK/BN polymorphisms in congenic strains on biological pathways in white adipose tissue. Hierarchical clustering of differentially regulated pathways in congenic strains illustrate shared and strain specific biological mechanisms regulated by polymorphisms in genomic blocks (A). Pathways downregulated or upregulated in congenics are shown in blue and red cells, respectively. Statistically significant changes are indicated by − and +. Enrichment plots of genes contributing to significant alterations of biological pathways in congenics (B–E) illustrate conserved patterns of pathway regulation in congenics BN.GK1p and 1u (B) and contrasting patterns in reciprocal congenic strains (BN.GK and GK.BN) targeting overlapping regions of chromosomes 7 (D) and 8 (C, E). Output images of GSEA show the number of genes (vertical lines) upregulated (red bars) or downregulated (blue bars) contributing to overall stimulation or inhibition of the pathways (green curves). Full lists of altered KEGG pathways in congenics are shown in Table S5 and details of differentially expressed genes between congenics and controls are given in Table S4. Details of genes contributing to enrichment of pathways in B–E are shown in Table S7.
Figure 5Overview of eQTL features in adipose tissue of GK × BN F2 hybrids. Genetic positions of statistically significant eQTLs are plotted against the LOD scores (A). Local and distant eQTLs are illustrated by plotting genetic positions of statistically significant eQTLs and the genomic position of the linked transcripts (B). Data from pairs of eQTL and linked transcripts mapped to the same chromosomes were used to determine the distribution of genomic distances between transcripts and genetic markers showing the strongest evidence of statistically significant linkage in the cross (C) and relationships with the significance of genetic linkages (D). Data from pairs of transcripts and eQTLs mapped to different chromosomes were selected to illustrate distant (trans) effects of genetic loci on gene transcription and trans-acting eQTL hotspots (smaller circles) (E). Chromosomes are color coded on the circle. The colors of the lines illustrate the effects of eQTLs mapped to the same chromosomes on the expression of distant genes. Details of eQTLs are given in Table S4. LOD, Logarithm of the odds.
Figure 6Correlation analysis of the effects of GK alleles on genome-wide gene expression in F2 hybrids and in inbred strains. The effects of GK alleles at statistically significant eQTLs (P-adjusted < 0.05) in the GK × BN F2 cross are plotted against expression ratio of corresponding genes significantly differential expressed (P-adjusted < 0.05) between GK and BN strains for all eQTLs (A) and cis- (B) and trans- (C) mediated eQTLs. The effects of GK alleles at eQTLs on gene expression regulation were compared in the F2 cross and in congenic strains for genome-wide gene expression data (D) and for genes mapped to congenic intervals (E). Details of differentially expressed genes between inbred strains and gene expression at eQTLs are given in Table S4.
KEGG pathways underlying eQTL biological effects in the white adipose tissue transcriptome in the GK × BN F2 cross
| Congenics | |||||||
|---|---|---|---|---|---|---|---|
| Rank | KEGG ID | Count | Size | Term | Upregulation | Downregulation | |
| 1 | 5332 | <0.01 | 17 | 34 | Graft | — | — |
| 2 | 4145 | <0.01 | 41 | 128 | Phagosome | — | — |
| 3 | 4940 | <0.01 | 18 | 39 | Type 1 diabetes mellitus | — | — |
| 4 | 5416 | <0.01 | 24 | 61 | Viral myocarditis | — | GK.BN7a, 8a, 10_7a |
| 5 | 4612 | <0.01 | 22 | 58 | Antigen processing and presentation | BN.GK7a | BN.GK1p; GK.BN10_7a |
| 6 | 5330 | <0.01 | 16 | 37 | Allograft rejection | — | — |
| 7 | 5320 | <0.01 | 16 | 39 | Autoimmune thyroid disease | — | — |
| 8 | 4514 | <0.01 | 29 | 92 | Cell adhesion molecules | — | BN.GK1v,10a; GK.BN8a, 10_7a |
| 9 | 1100 | <0.01 | 167 | 798 | Metabolic pathways | — | — |
| 10 | 5140 | <0.01 | 19 | 53 | Leishmaniasis | BN.GK7a, 7d | GK.BN10_7a |
| 11 | 5322 | <0.01 | 19 | 59 | Systemic lupus erythematosus | — | — |
| 12 | 380 | <0.01 | 11 | 27 | Tryptophan metabolism | — | — |
| 13 | 5150 | 0.01 | 12 | 33 | — | — | |
| 14 | 250 | 0.01 | 9 | 22 | Alanine, aspartate, and glutamate metabolism | — | — |
| 15 | 280 | 0.01 | 12 | 34 | Valine, leucine, and isoleucine degradation | BN.GK5a; GK.BN7a, 8a, 10_7a | BN.GK7d |
| 16 | 360 | 0.01 | 5 | 9 | Phenylalanine metabolism | — | — |
| 17 | 350 | 0.01 | 7 | 16 | Tyrosine metabolism | — | — |
| 18 | 650 | 0.02 | 7 | 17 | Butanoate metabolism | — | — |
| 19 | 71 | 0.02 | 11 | 33 | Fatty acid metabolism | GK.BN7a, 8a | — |
| 20 | 790 | 0.02 | 4 | 7 | Folate biosynthesis | — | — |
| 21 | 5144 | 0.02 | 11 | 34 | Malaria | — | — |
| 22 | 511 | 0.02 | 6 | 14 | Other glycan degradation | — | — |
| 23 | 4650 | 0.02 | 19 | 70 | Natural killer cell-mediated cytotoxicity | BN.GK7a, 8b | GK.BN7a, 8a, 10_7a |
| 24 | 4640 | 0.02 | 15 | 52 | Hematopoietic cell lineage | — | GK.BN10_7a |
| 25 | 982 | 0.03 | 13 | 44 | Drug metabolism – cytochrome P450 | GK.BN7a, 8a, 10_7a | — |
| 26 | 270 | 0.03 | 9 | 27 | Cysteine and methionine metabolism | BN.GK1v; GK.BN7a | — |
| 27 | 4975 | 0.03 | 9 | 27 | Fat digestion and absorption | — | — |
| 28 | 450 | 0.04 | 5 | 12 | Selenocompound metabolism | — | — |
| 29 | 4970 | 0.05 | 15 | 57 | Salivary secretion | — | — |
| 30 | 4512 | 0.05 | 15 | 57 | Extra-cellular matrix-receptor interaction | — | BN.GK1b, 1q, 1v, 5c, 10a; GK.BN8a, 10_7a |
Data were analyzed with sex and cross as additive covariates. Congenic strains showing upregulation or downregulation in pathways identified in F2 hybrids are listed. Details of pathways can be found at www.genome.jp/kegg/.
Figure 7Summary of transcriptome results among inbred strains and eQTL data in GK × BN F2 hybrids. The number of statistically significant eQTLs (green circle) and differentially expressed genes between GK and BN (red circle) and between congenics and controls (blue circle) are reported. Concordant data between the different experimental groups correspond to genes showing consistent allelic effects on the direction of expression changes.